Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Leukemia. 2021 Mar 2;35(9):2592–2601. doi: 10.1038/s41375-021-01183-8

Figure 1: Myelofibrosis-free survival (MFS) and overall survival (OS) of PV patients.

Figure 1:

A MFS of all patients, B OS of all patients, C MFS of all patients by ELN risk, D OS of all patients by ELN risk, E MFS of low-risk patients by treatment group, F OS of low-risk patients by treatment group, G MFS of high-risk patients by treatment group, H OS of high-risk patients by treatment group.